What is the current stock price of Anbio Biotechnology Class A Ordinary Shares (NNNN)?

As of the latest market data, Anbio Biotechnology Class A Ordinary Shares (NNNN) is trading at $27.15. The stock has seen a loss of -2.34% today.

Does Anbio Biotechnology Class A Ordinary Shares (NNNN) pay a dividend?

Based on current data, Anbio Biotechnology Class A Ordinary Shares does not have a confirmed active dividend policy.

What is the market cap of Anbio Biotechnology Class A Ordinary Shares?

The current market capitalization of Anbio Biotechnology Class A Ordinary Shares (NNNN) is approximately unavailable.

NNNN

Anbio Biotechnology Class A Ordinary Shares·Healthcare

27.15

2.338%(−0.65)

Market Closed

32.00

17.864%(+4.85)

After Hours

Last Updated: — ET

52W L: $6.0552W H: $55.65

NNNN NEWS

defenseworld.net

Mar 9

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review

Anbio Biotechnology (NASDAQ: NNNN - Get Free Report) and Oncocyte (NASDAQ: IMDX - Get Free Report) are both manufacturing companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, profitability, earnings and analyst recommendations. Profitability This table compares Anbio Biotechnology and Oncocyte's net

Company Profile

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

IPO Date

2025-02-19

Beta

8.49

Websitewww.anbio.com↗

NNNN

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review

Head-To-Head Contrast: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN)

Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN)

Financial Comparison: Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX)

Analyzing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX)

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Financial Comparison